These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 16355096)
1. Angiocidal effect of Cyclosporin A: a new therapeutic approach for pathogenic angiogenesis. Wilasrusmee C; Yusupov I; Ondocin P; Bruch D; Kittur S; Wilasrusmee S; Kittur DS Int Angiol; 2005 Dec; 24(4):372-9. PubMed ID: 16355096 [TBL] [Abstract][Full Text] [Related]
2. Amelioration of cyclosporin A effect on microvasculature by endothelin inhibitor. Wilasrusmee C; Ondocin P; Bruch D; Shah G; Kittur S; Wilasrusmee S; Kittur DS Surgery; 2003 Aug; 134(2):384-9. PubMed ID: 12947345 [TBL] [Abstract][Full Text] [Related]
3. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Passaniti A; Taylor RM; Pili R; Guo Y; Long PV; Haney JA; Pauly RR; Grant DS; Martin GR Lab Invest; 1992 Oct; 67(4):519-28. PubMed ID: 1279270 [TBL] [Abstract][Full Text] [Related]
4. Histidine-rich glycoprotein inhibited high mobility group box 1 in complex with heparin-induced angiogenesis in matrigel plug assay. Wake H; Mori S; Liu K; Takahashi HK; Nishibori M Eur J Pharmacol; 2009 Nov; 623(1-3):89-95. PubMed ID: 19786011 [TBL] [Abstract][Full Text] [Related]
5. Differential role of platelet granular mediators in angiogenesis. Brill A; Elinav H; Varon D Cardiovasc Res; 2004 Aug; 63(2):226-35. PubMed ID: 15249180 [TBL] [Abstract][Full Text] [Related]
6. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol. Shibata A; Nakagawa K; Sookwong P; Tsuzuki T; Oikawa S; Miyazawa T Biochem Pharmacol; 2008 Aug; 76(3):330-9. PubMed ID: 18599020 [TBL] [Abstract][Full Text] [Related]
8. Effect of acetyl 11-keto beta-boswellic acid on metastatic growth factor responsible for angiogenesis. Singh SK; Bhusari S; Singh R; Saxena A; Mondhe D; Qazi GN Vascul Pharmacol; 2007 May; 46(5):333-7. PubMed ID: 17257903 [TBL] [Abstract][Full Text] [Related]
9. A new in vitro model to study endothelial injury. Wilasrusmee C; Da Silva M; Singh B; Kittur S; Siddiqui J; Bruch D; Wilasrusmee S; Kittur DS J Surg Res; 2002 May; 104(2):131-6. PubMed ID: 12020132 [TBL] [Abstract][Full Text] [Related]
10. The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis. Carmi Y; Voronov E; Dotan S; Lahat N; Rahat MA; Fogel M; Huszar M; White MR; Dinarello CA; Apte RN J Immunol; 2009 Oct; 183(7):4705-14. PubMed ID: 19752225 [TBL] [Abstract][Full Text] [Related]
11. The influence of nitric oxide synthase 2 on cutaneous wound angiogenesis. Chin LC; Kumar P; Palmer JA; Rophael JA; Dolderer JH; Thomas GP; Morrison WA; Penington AJ; Stewart AG; Mitchell GM Br J Dermatol; 2011 Dec; 165(6):1223-35. PubMed ID: 21895624 [TBL] [Abstract][Full Text] [Related]
13. Corneal neovascularization induced by xenografts or chemical cautery. Inhibition by cyclosporin A. Benelli U; Ross JR; Nardi M; Klintworth GK Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):274-82. PubMed ID: 9040459 [TBL] [Abstract][Full Text] [Related]
14. Angiogenic synergy of bFGF and VEGF is antagonized by Angiopoietin-2 in a modified in vivo Matrigel assay. Ley CD; Olsen MW; Lund EL; Kristjansen PE Microvasc Res; 2004 Nov; 68(3):161-8. PubMed ID: 15501235 [TBL] [Abstract][Full Text] [Related]
15. The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1. Schmid G; Guba M; Ischenko I; Papyan A; Joka M; Schrepfer S; Bruns CJ; Jauch KW; Heeschen C; Graeb C J Cell Biochem; 2007 May; 101(1):259-70. PubMed ID: 17203465 [TBL] [Abstract][Full Text] [Related]
16. [Effect of huangqi and dangshen extraction on angiogenesis in Matrigel implant of mice]. Bai CQ; Song YF; Jian W; Wang DT; Ma CB Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 May; 24(5):498-9. PubMed ID: 18466712 [TBL] [Abstract][Full Text] [Related]
17. A versatile in vivo chamber angiogenesis assay for measuring anti-angiogenic activity in mice. Kragh M; Hjarnaa PJ; Bramm E; Binderup L Oncol Rep; 2004 Feb; 11(2):303-7. PubMed ID: 14719059 [TBL] [Abstract][Full Text] [Related]
18. The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis. Naumova E; Ubezio P; Garofalo A; Borsotti P; Cassis L; Riccardi E; Scanziani E; Eccles SA; Bani MR; Giavazzi R Clin Cancer Res; 2006 Mar; 12(6):1839-49. PubMed ID: 16551869 [TBL] [Abstract][Full Text] [Related]
19. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE. Roscoe WA; Welsh ME; Carter DE; Karlik SJ J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483 [TBL] [Abstract][Full Text] [Related]
20. Vascular-specific quantification in an in vivo Matrigel chamber angiogenesis assay. Baker JH; Huxham LA; Kyle AH; Lam KK; Minchinton AI Microvasc Res; 2006 Mar; 71(2):69-75. PubMed ID: 16545400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]